Diabetology and Metabolic Syndrome

Top Research Topics at Diabetology & Metabolic Syndrome?

The primary areas of discussion in Diabetology & Metabolic Syndrome are Diabetes mellitus, Internal medicine, Endocrinology, Type 2 diabetes and Metabolic syndrome. The journal facilitates discussions on Diabetes mellitus that incorporate concepts from other fields like Obesity, Insulin and Bioinformatics. Overweight is a major topic of Obesity research presented in the journal.

The studies on Internal medicine discussed can also contribute to research in the domains of Gastroenterology and Type 1 diabetes. Adipose tissue, Adiponectin, Adipokine, Streptozotocin and Blood pressure are some of the facets of Endocrinology tackled in Diabetology & Metabolic Syndrome. Type 2 diabetes and Disease are closely related fields of research discussed in Diabetology & Metabolic Syndrome.

Diabetology & Metabolic Syndrome addresses concerns in Metabolic syndrome which are intertwined with other disciplines, such as Cross-sectional study, Anthropometry and Dyslipidemia. Many of the studies tackled connect Glycemic with a similar field of study like Hypoglycemia.

• Diabetes mellitus (81.92%)
• Internal medicine (68.95%)
• Endocrinology (43.73%)

What are the most cited papers published in the journal?

• Metformin: an old but still the best treatment for type 2 diabetes (315 citations)
• Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. (257 citations)
• High plasma uric acid concentration: causes and consequences (222 citations)

Research areas of the most cited articles at Diabetology & Metabolic Syndrome:

The published articles mainly tackle studies in Diabetes mellitus, Internal medicine, Endocrinology, Metabolic syndrome and Insulin resistance. The most cited articles focus on Diabetes mellitus but the discussions also offer insight into other areas such as Obesity, Waist and Blood pressure. The studies tackled in the most cited articles, which mainly focus on Internal medicine, apply to Type 2 diabetes as well.

What topics the last edition of the journal is best known for?

• Internal medicine
• Diabetes mellitus
• Gene

The previous edition focused in particular on these issues:

Diabetology & Metabolic Syndrome aims to foster the development of research in Diabetes mellitus, Internal medicine, Type 2 diabetes, Insulin resistance and Metabolic syndrome. Diabetology & Metabolic Syndrome explores topics in Diabetes mellitus which can be helpful for research in disciplines like Obesity and Insulin. While work presented in Diabetology & Metabolic Syndrome provided substantial information on Internal medicine, it also covered topics in Gastroenterology and Endocrinology.

Diabetology & Metabolic Syndrome focuses on Endocrinology as well as the interrelated topic of Inflammation. Diabetology & Metabolic Syndrome explores themes in Type 2 diabetes like Glycated hemoglobin and links them with other fields of study like In patient. The journal explores research in Metabolic syndrome alongside concepts in Waist and other areas of study in Hazard ratio and Polycystic ovary.

The most cited articles from the last journal are:

• Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications (8 citations)
• Knockdown of circ-FANCA alleviates LPS-induced HK2 cell injury via targeting miR-93-5p/OXSR1 axis in septic acute kidney injury. (5 citations)
• Differences in the roles of types 1 and 2 diabetes in the susceptibility to the risk of fracture: a systematic review and meta-analysis. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Diabetology & Metabolic Syndrome (based on the number of publications) are:

• Marília B. Gomes (39 papers) published 2 papers at the last edition the same number as at the previous edition,
• Lenita Zajdenverg (23 papers) absent at the last edition,
• Luis Henrique Santos Canani (22 papers) published 1 paper at the last edition,
• Melanie Rodacki (22 papers) published 1 paper at the last edition, 3 less than at the previous edition,
• Carlos Antonio Negrato (18 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Diabetology & Metabolic Syndrome (based on the number of publications) are:

• University of São Paulo (109 papers) published 5 papers at the last edition, 2 less than at the previous edition,
• Universidade Federal do Rio Grande do Sul (84 papers) published 5 papers at the last edition, 2 less than at the previous edition,
• Federal University of São Paulo (66 papers) published 5 papers at the last edition, 1 more than at the previous edition,
• State University of Campinas (46 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• Rio de Janeiro State University (37 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.50% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.00% of all publications and 52.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Diabetes, Obesity, and Nursing: An Interdisciplinary Approach

An important aspect of dealing with Diabetology & Metabolic Syndrome involves the role of nursing in serving patients grappling with these conditions. Given the emphasis on the interdisciplinary approach observed within this journal, it is important to highlight the importance of the nursing role, especially those specializing in diabetes care and obesity management. Nursing has a significant part to play in handling patients with Diabetes mellitus and Metabolic syndrome. They are often at the forefront of patient care and manage day-to-day patient needs, medication management, patient counseling, and providing necessary health education to both patients and their families. In many cases, nurses act as a bridge between patients and their doctors, interpreting medical jargon into understandable language and offering pertinent advice related to the care of the disease. Furthermore, the rise in online nursing programs targeting these concerns is an educational trend worth mentioning. For instance, the online nursing programs in North Carolina have become a popular choice for those who want to specialize in diabetes care and metabolic disorders. Such programs offer advanced knowledge and training that prepare nurses to effectively help patients manage and, where possible, prevent these conditions. In conclusion, the part played by nursing in Diabetes Mellitus and Metabolic Syndrome treatment cannot be understated. Their role goes beyond just medication administration to include patient education, emotional counselling, nutritional guidance, and so much more. This is particularly the case for those nurses who have undergone specialized training in these areas, such as those graduating from the aforementioned online programs.